Chad Therapeutics Declares Stock Split
- Share via
Chad Therapeutics Inc., a Chatsworth maker of oxygen-conserving devices used by pulmonary patients, declared a two-for-one stock split.
The split is effective for shareholders of record Oct. 1. The additional shares will be distributed Oct. 15.
Chad said the split increases its total shares outstanding to 6,174,416.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
